Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody & Protein Engineering
Novartis Withdraws Tislelizumab Submission
Novartis scraps US submission of tislelizumab as a monotherapy for non-small cell lung cancer.
Drug Discovery & Development
Addressing Immunotherapy Resistance Through PVRIG And TIGIT Blockade
In this interview, Eran Ophir discusses Compugen's exciting approach to immune checkpoint inhibitors for the treatment of cancer and what makes them stand out from the crowd.
New Speakers Announced: Vaccines Europe Congress 2022
Exciting updates revealed about upcoming Vaccines Europe: In-Person congress happening 29-30 November 2022.
Drug Discovery & Development
Using Live Gut Bacteria as a Co-Therapy for Checkpoint Inhibitors
Microbiotica’s live bacterial therapeutic is currently manufacturing for phase Ib trials in 2023.
Antibody & Protein Engineering
Blood Test Predicts Presence of Beta-Amyloid in Brain
A study by the National Institute of Ageing found that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain.
Drug Discovery & Development
Microbiome Solutions to Immuno-Oncology Problems
Investigating the role of the microbiota in checkpoint inhibitor response.
US Doubles its Supply of Monkeypox Vaccines
The US government has more than doubled its supply of Monkeypox vaccines amidst rising fears.
NextGen Therapeutics
AstraZeneca Buys T Cell Engager for $100 Million
Pharma giant makes a major investment in improving the standards of care in B cell malignancies.
Antibody & Protein Engineering
Recommended Approval for AbbVie’s Rinvoq Treatment
AbbVie announces official recommended approval of it Rinvoq treatment for adults with active non-radiographic axial spondyloarthritis.
Bioanalysis
The Countdown Begins: How ADCs will Become the Next Generation of Biologics Therapeutics
Key opinion leaders from AbbVie, Ambrx Inc, and Antikor Biopharma talk about the cutting-edge technology’s promise for better therapeutic index.
Immuno-Oncology
Investigating the Core Tenet of Immunotherapy: MHC-I Peptide-Receptor Complexes
Axel Ducret, a Roche Senior Principal Scientist, takes us through his work on one of the most important cellular mechanisms in immunotherapy.
NextGen Therapeutics
Why Drug Delivery is Key to New Drug Discovery
Method of delivery is just as important as discovering new medicines.